News | Magnetic Resonance Imaging (MRI) | January 18, 2024

With this new approval, people with a Proclaim DRG neurostimulation system can soon receive full-body MRI scans

With this new approval, people with a Proclaim DRG neurostimulation system can soon receive full-body MRI scans

January 18, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling for its dorsal root ganglion (DRG) stimulation therapy, the Proclaim DRG neurostimulation system, which allows patients to receive full-body MRI scans while implanted with the device.2* The Proclaim DRG neurostimulation system is the only FDA-approved DRG technology, providing targeted relief for people with complex regional pain syndrome (CRPS) types I and II of the lower limbs by stimulating the DRG, which are clusters of nerve cells found along the spine.3

CRPS is a rare and painful condition that affects about 200,000 people in the U.S. each year.4 Characterized by a constant or intermittent burning, stinging or tearing sensation, CRPS has been found to be more excruciating than childbirth or amputation of a limb.5 For people who suffer from the syndrome and struggle to control the pain, Proclaim DRG stimulation can be an effective option, as four out of five people who receive the therapy experience significant pain relief and improved quality of life.6

MRI is one of the most widely used technologies to create detailed images of the inside of the body to inform diagnoses and treatment approaches for people with chronic pain.MRIs can be used to help assess the progression of CRPS.8 In these situations, an option like the Proclaim DRG therapy, which allows patients to receive MRI scans anywhere in the body within approved parameters, can be invaluable to the patient and radiologist.

"The ability to do full-body MRI scans with the Proclaim DRG neurostimulation system means that, as physicians, we can ensure that people are receiving the care they need in a timely manner because they aren’t having to search for a facility that can accommodate special MRI settings for their device," said Timothy Deer, M.D., DABPM, president and chief executive officer of the Spine and Nerve Centers of the Virginias in Charleston, W.Va. "With these expanded MRI capabilities, we no longer need to sacrifice superior pain relief and quality of life outcomes in exchange for MRI needs."

With the expanded MRI labeling, Abbott’s Proclaim DRG neurostimulation system will offer:

· Full-body scans for new and existing patients^, providing near and long-term flexibility for their imaging needs

· Safe scanning of any body part with standard MRI scanners^, making finding an imaging center easier and more straightforward for patients and doctors

· Compatibility with 50cm SlimTip DRG leads

"As we continue to work holistically across chronic pain care, we’re excited to see this new MRI expanded indication for our proprietary and unique Dorsal Root Ganglion Stimulation therapy become another valuable tool in the hands of treating physicians helping people get back to living a life on their terms," said Pedro Malha, vice president, neuromodulation, Abbott.

For more information: www.abbott.com

References:

1Abbott. Survey on MRI labeling. Completion date: February 1, 2023; Austin, Texas. N = 25.

2 U.S. Food and Drug Administration. See https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150004S063.

3 Abbott. Proclaim DRG Neurostimulation System Clinician’s Manual. Plano, TX. 2018.

4 National Organization of Rare Diseases. Feb. 8, 2023. Complex Regional Pain Syndrome. https://rarediseases.org/rare-diseases/reflex-sympathetic-dystrophy-syndrome/. Accessed Nov. 8, 2023.

Lee DH, Noh EC, Kim YC, et al. Risk Factors for Suicidal Ideation among Patients with Complex Regional Pain Syndrome. Psychiatry Investig. 2014;11(1):32-38. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942549/

Deer TR, Levy RM, Kramer J, et al. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain. 2017;158(4):669-681. https://pubmed.ncbi.nlm.nih.gov/28030470/

7 Martucci, K., Ng, P., & Mackey, S. (2014). Neuroimaging chronic pain: what have we learned and where are we going?. Future neurology, 9(6), 615–626. https://doi.org/10.2217/fnl.14.57

8 Stanford Medicine. Complex Regional Pain Syndrome (CRPS)https://med.stanford.edu/pain/about/chronic-pain/crps.html Accessed. Nov. 8, 2023.


Related Content

News | Prostate Cancer

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time July 09, 2025
arrow
News | Computed Tomography (CT)

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University ...

Time July 03, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise[1] MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging ...

Time June 27, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | PET Imaging

Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label ...

Time June 24, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 24, 2025 —Smart Soft Healthcare has announced that CoLumbo, the company's advanced AI spine assistant, has received ...

Time June 24, 2025
arrow
News | Contrast Media

June 17, 2025 — Bayer has announced the submission of a New Drug Application (NDA) to the US Food and Drug ...

Time June 20, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

June 17, 2025 — Royal Philips has announced the global launch of the Flash Ultrasound System 5100 POC — a new point-of ...

Time June 19, 2025
arrow
Subscribe Now